BMRN logo

BioMarin Pharmaceutical Inc. (BMRN) Net Income

Annual Net Income:

$426.86M+$259.21M(+154.62%)
December 31, 2024

Summary

  • As of today, BMRN annual net profit is $426.86 million, with the most recent change of +$259.21 million (+154.62%) on December 31, 2024.
  • During the last 3 years, BMRN annual net income has risen by +$490.94 million (+766.13%).
  • BMRN annual net income is now -50.31% below its all-time high of $859.10 million, reached on December 31, 2020.

Performance

BMRN Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

Quarterly Net Income:

$240.53M+$54.85M(+29.54%)
June 30, 2025

Summary

  • As of today, BMRN quarterly net profit is $240.53 million, with the most recent change of +$54.85 million (+29.54%) on June 30, 2025.
  • Over the past year, BMRN quarterly net income has increased by +$133.36 million (+124.43%).
  • BMRN quarterly net income is now -69.35% below its all-time high of $784.80 million, reached on September 30, 2020.

Performance

BMRN Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

TTM Net Income:

$657.24M+$133.36M(+25.46%)
June 30, 2025

Summary

  • As of today, BMRN TTM net profit is $657.24 million, with the most recent change of +$133.36 million (+25.46%) on June 30, 2025.
  • Over the past year, BMRN TTM net income has increased by +$400.65 million (+156.15%).
  • BMRN TTM net income is now -23.50% below its all-time high of $859.10 million, reached on December 31, 2020.

Performance

BMRN TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

BMRN Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+154.6%+124.4%+156.2%
3Y3 Years+766.1%+769.5%+1115.5%
5Y5 Years+1889.9%+924.2%-22.9%

BMRN Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+766.1%at high+3715.9%at high+817.7%
5Y5-Year-50.3%+766.1%-69.3%+515.4%-23.5%+1125.7%
All-TimeAll-Time-50.3%+167.7%-69.3%+157.4%-23.5%+204.3%

BMRN Net Income History

DateAnnualQuarterlyTTM
Jun 2025
-
$240.53M(+29.5%)
$657.24M(+25.5%)
Mar 2025
-
$185.69M(+48.6%)
$523.88M(+22.7%)
Dec 2024
$426.86M(+154.6%)
$124.94M(+17.8%)
$426.86M(+32.4%)
Sep 2024
-
$106.08M(-1.0%)
$322.29M(+25.6%)
Jun 2024
-
$107.17M(+20.9%)
$256.59M(+24.9%)
Mar 2024
-
$88.66M(+335.2%)
$205.46M(+22.6%)
Dec 2023
$167.65M(+18.4%)
$20.38M(-49.5%)
$167.65M(+14.0%)
Sep 2023
-
$40.38M(-27.9%)
$147.02M(+47.0%)
Jun 2023
-
$56.04M(+10.2%)
$99.99M(+39.6%)
Mar 2023
-
$50.85M(>+9900.0%)
$71.61M(-49.4%)
Dec 2022
$141.56M(+320.9%)
-$249.00K(+96.3%)
$141.56M(+68.7%)
Sep 2022
-
-$6.65M(-124.0%)
$83.91M(+55.2%)
Jun 2022
-
$27.66M(-77.1%)
$54.07M(+37.4%)
Mar 2022
-
$120.80M(+308.6%)
$39.35M(+161.4%)
Dec 2021
-$64.08M(-107.5%)
-$57.90M(-58.7%)
-$64.08M(-502.6%)
Sep 2021
-
-$36.49M(-382.0%)
$15.92M(-98.1%)
Jun 2021
-
$12.94M(-25.5%)
$837.21M(+5.3%)
Mar 2021
-
$17.37M(-21.4%)
$795.09M(-7.5%)
Dec 2020
$859.10M(+3702.4%)
$22.10M(-97.2%)
$859.10M(+0.8%)
Sep 2020
-
$784.80M(+2789.2%)
$852.02M(+596.9%)
Jun 2020
-
-$29.18M(-135.9%)
$122.26M(+7.2%)
Mar 2020
-
$81.38M(+441.7%)
$114.01M(+578.1%)
Dec 2019
-$23.85M(+69.1%)
$15.02M(-72.7%)
-$23.85M(+43.9%)
Sep 2019
-
$55.04M(+247.0%)
-$42.52M(+61.4%)
Jun 2019
-
-$37.44M(+33.7%)
-$110.18M(-23.1%)
Mar 2019
-
-$56.47M(-1447.2%)
-$89.53M(-16.0%)
Dec 2018
-$77.21M(+34.0%)
-$3.65M(+71.1%)
-$77.21M(+38.2%)
Sep 2018
-
-$12.62M(+24.8%)
-$124.95M(-0.1%)
Jun 2018
-
-$16.79M(+62.0%)
-$124.86M(+13.8%)
Mar 2018
-
-$44.15M(+14.1%)
-$144.90M(-23.8%)
Dec 2017
-$117.04M(+81.4%)
-$51.39M(-310.2%)
-$117.04M(+25.2%)
Sep 2017
-
-$12.53M(+66.0%)
-$156.37M(+13.7%)
Jun 2017
-
-$36.83M(-126.1%)
-$181.27M(+67.8%)
Mar 2017
-
-$16.29M(+82.0%)
-$563.45M(+10.6%)
Dec 2016
-$630.21M(-266.8%)
-$90.72M(-142.4%)
-$630.21M(-33.8%)
Sep 2016
-
-$37.42M(+91.1%)
-$470.87M(+10.2%)
Jun 2016
-
-$419.01M(-404.5%)
-$524.37M(-179.9%)
Mar 2016
-
-$83.05M(-221.0%)
-$187.35M(-9.1%)
Dec 2015
-$171.80M(-28.2%)
$68.62M(+175.5%)
-$171.80M(+44.6%)
Sep 2015
-
-$90.93M(-10.9%)
-$310.21M(-46.4%)
Jun 2015
-
-$81.99M(-21.5%)
-$211.84M(-29.7%)
Mar 2015
-
-$67.50M(+3.3%)
-$163.35M(-21.9%)
Dec 2014
-$133.97M(+24.0%)
-$69.80M(-1037.5%)
-$133.97M(-6.2%)
Sep 2014
-
$7.45M(+122.2%)
-$126.16M(+32.4%)
Jun 2014
-
-$33.50M(+12.1%)
-$186.63M(-6.9%)
Mar 2014
-
-$38.12M(+38.5%)
-$174.66M(+1.0%)
Dec 2013
-$176.35M(-54.2%)
-$61.99M(-16.9%)
-$176.35M(-5.4%)
Sep 2013
-
-$53.02M(-146.2%)
-$167.38M(-39.8%)
Jun 2013
-
-$21.53M(+45.9%)
-$119.71M(+8.0%)
Mar 2013
-
-$39.81M(+24.9%)
-$130.19M(-13.9%)
Dec 2012
-$114.35M(-112.4%)
-$53.01M(-889.6%)
-$114.35M(-29.8%)
Sep 2012
-
-$5.36M(+83.3%)
-$88.07M(+12.3%)
Jun 2012
-
-$32.01M(-33.5%)
-$100.37M(-36.7%)
Mar 2012
-
-$23.97M(+10.3%)
-$73.44M(-36.4%)
DateAnnualQuarterlyTTM
Dec 2011
-$53.84M(-126.2%)
-$26.73M(-51.4%)
-$53.84M(-37.0%)
Sep 2011
-
-$17.65M(-247.7%)
-$39.29M(-120.1%)
Jun 2011
-
-$5.08M(-16.2%)
$195.70M(-2.3%)
Mar 2011
-
-$4.37M(+64.1%)
$200.30M(-2.7%)
Dec 2010
$205.82M(>+9900.0%)
-$12.19M(-105.6%)
$205.82M(-7.6%)
Sep 2010
-
$217.33M(>+9900.0%)
$222.72M(+1752.1%)
Jun 2010
-
-$477.00K(-141.4%)
$12.03M(-13.0%)
Mar 2010
-
$1.15M(-75.6%)
$13.81M(+2924.9%)
Dec 2009
-$488.00K(-101.6%)
$4.71M(-29.1%)
-$489.00K(-102.5%)
Sep 2009
-
$6.64M(+406.1%)
$19.31M(+43.1%)
Jun 2009
-
$1.31M(+110.0%)
$13.49M(-15.6%)
Mar 2009
-
-$13.15M(-153.7%)
$15.99M(-48.1%)
Dec 2008
$30.83M(+295.1%)
$24.51M(+2856.1%)
$30.83M(+246.6%)
Sep 2008
-
$829.00K(-78.2%)
$8.90M(+212.0%)
Jun 2008
-
$3.81M(+126.0%)
$2.85M(+159.1%)
Mar 2008
-
$1.69M(-34.4%)
-$4.82M(+69.5%)
Dec 2007
-$15.80M(+44.6%)
$2.57M(+149.3%)
-$15.80M(+45.1%)
Sep 2007
-
-$5.22M(-35.0%)
-$28.76M(+6.0%)
Jun 2007
-
-$3.86M(+58.4%)
-$30.58M(-9.1%)
Mar 2007
-
-$9.29M(+10.6%)
-$28.05M(+1.7%)
Dec 2006
-$28.53M(+61.6%)
-$10.39M(-47.7%)
-$28.53M(+13.9%)
Sep 2006
-
-$7.04M(-431.0%)
-$33.14M(+20.3%)
Jun 2006
-
-$1.32M(+86.5%)
-$41.58M(+32.5%)
Mar 2006
-
-$9.78M(+34.8%)
-$61.59M(+17.1%)
Dec 2005
-$74.27M(+60.4%)
-$15.00M(+3.1%)
-$74.27M(+47.6%)
Sep 2005
-
-$15.48M(+27.5%)
-$141.70M(+9.0%)
Jun 2005
-
-$21.34M(+5.0%)
-$155.70M(+18.0%)
Mar 2005
-
-$22.46M(+72.8%)
-$189.96M(-1.3%)
Dec 2004
-$187.44M(-145.4%)
-$82.42M(-179.6%)
-$187.44M(-43.4%)
Sep 2004
-
-$29.48M(+47.0%)
-$130.75M(-6.7%)
Jun 2004
-
-$55.60M(-178.8%)
-$122.56M(-61.1%)
Mar 2004
-
-$19.95M(+22.5%)
-$76.06M(+0.4%)
Dec 2003
-$76.38M(+1.3%)
-$25.73M(-20.8%)
-$76.38M(-9.1%)
Sep 2003
-
-$21.29M(-134.0%)
-$69.97M(-6.7%)
Jun 2003
-
-$9.10M(+55.1%)
-$65.57M(+7.7%)
Mar 2003
-
-$20.26M(-4.8%)
-$71.05M(+8.2%)
Dec 2002
-$77.37M(-34.7%)
-$19.32M(-14.4%)
-$77.37M(+16.2%)
Sep 2002
-
-$16.89M(-15.9%)
-$92.33M(-6.8%)
Jun 2002
-
-$14.57M(+45.2%)
-$86.46M(-3.1%)
Mar 2002
-
-$26.58M(+22.5%)
-$83.85M(-25.2%)
Dec 2001
-$57.43M(-53.7%)
-$34.28M(-211.2%)
-$66.97M(-55.5%)
Sep 2001
-
-$11.02M(+8.0%)
-$43.08M(-7.1%)
Jun 2001
-
-$11.97M(-23.4%)
-$40.21M(-13.8%)
Mar 2001
-
-$9.70M(+6.7%)
-$35.33M(+5.4%)
Dec 2000
-$37.36M(-33.1%)
-$10.39M(-27.6%)
-$37.36M(-3.8%)
Sep 2000
-
-$8.15M(-15.0%)
-$36.01M(-1.4%)
Jun 2000
-
-$7.09M(+39.6%)
-$35.50M(-0.9%)
Mar 2000
-
-$11.74M(-29.9%)
-$35.20M(-25.4%)
Dec 1999
-$28.07M(-128.0%)
-$9.04M(-18.3%)
-$28.07M(-47.5%)
Sep 1999
-
-$7.64M(-12.7%)
-$19.03M(-67.1%)
Jun 1999
-
-$6.78M(-47.1%)
-$11.39M(-147.1%)
Mar 1999
-
-$4.61M
-$4.61M
Dec 1998
-$12.31M(-345.7%)
-
-
Dec 1997
-$2.76M
-
-

FAQ

  • What is BioMarin Pharmaceutical Inc. annual net profit?
  • What is the all-time high annual net income for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. annual net income year-on-year change?
  • What is BioMarin Pharmaceutical Inc. quarterly net profit?
  • What is the all-time high quarterly net income for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. quarterly net income year-on-year change?
  • What is BioMarin Pharmaceutical Inc. TTM net profit?
  • What is the all-time high TTM net income for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. TTM net income year-on-year change?

What is BioMarin Pharmaceutical Inc. annual net profit?

The current annual net income of BMRN is $426.86M

What is the all-time high annual net income for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high annual net profit is $859.10M

What is BioMarin Pharmaceutical Inc. annual net income year-on-year change?

Over the past year, BMRN annual net profit has changed by +$259.21M (+154.62%)

What is BioMarin Pharmaceutical Inc. quarterly net profit?

The current quarterly net income of BMRN is $240.53M

What is the all-time high quarterly net income for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high quarterly net profit is $784.80M

What is BioMarin Pharmaceutical Inc. quarterly net income year-on-year change?

Over the past year, BMRN quarterly net profit has changed by +$133.36M (+124.43%)

What is BioMarin Pharmaceutical Inc. TTM net profit?

The current TTM net income of BMRN is $657.24M

What is the all-time high TTM net income for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high TTM net profit is $859.10M

What is BioMarin Pharmaceutical Inc. TTM net income year-on-year change?

Over the past year, BMRN TTM net profit has changed by +$400.65M (+156.15%)
On this page